However, both tau phosphorylation and cognitive decline were alleviated by the administration of an inhibitor of GSK3β or by the knockout of the tau protein-encoding gene MAPT, indicating that abnormal tau phosphorylation might be an important inducer of POCD33, 34. The gene discussed is MAPT; the disease is Mental deterioration.